Annual Retained Earnings
-$315.31 M
-$42.49 M-15.58%
31 December 2023
Summary:
Compass Therapeutics annual retained earnings is currently -$315.31 million, with the most recent change of -$42.49 million (-15.58%) on 31 December 2023. During the last 3 years, it has fallen by -$163.90 million (-108.25%). CMPX annual retained earnings is now -261.74% below its all-time high of -$87.16 million, reached on 01 December 2018.CMPX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$349.65 M
-$10.48 M-3.09%
01 September 2024
Summary:
Compass Therapeutics quarterly retained earnings is currently -$349.65 million, with the most recent change of -$10.48 million (-3.09%) on 01 September 2024. Over the past year, it has dropped by -$47.76 million (-15.82%). CMPX quarterly retained earnings is now -186.82% below its all-time high of -$121.91 million, reached on 01 December 2019.CMPX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.6% | -15.8% |
| 3 y3 years | -108.3% | -58.5% |
| 5 y5 years | -261.7% | - |
CMPX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -108.3% | at low | -58.5% | at low |
| 5 y | 5 years | -261.7% | at low | -186.8% | at low |
| alltime | all time | -261.7% | at low | -186.8% | at low |
Compass Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$349.65 M(+3.1%) |
| June 2024 | - | -$339.17 M(+4.0%) |
| Mar 2024 | - | -$326.10 M(+3.4%) |
| Dec 2023 | -$315.31 M(+15.6%) | -$315.31 M(+4.4%) |
| Sept 2023 | - | -$301.89 M(+3.4%) |
| June 2023 | - | -$291.93 M(+4.0%) |
| Mar 2023 | - | -$280.65 M(+2.9%) |
| Dec 2022 | -$272.81 M | -$272.81 M(+4.4%) |
| Sept 2022 | - | -$261.22 M(+4.8%) |
| June 2022 | - | -$249.25 M(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$240.75 M(+3.1%) |
| Dec 2021 | -$233.59 M(+54.3%) | - |
| Dec 2021 | - | -$233.59 M(+5.9%) |
| Sept 2021 | - | -$220.61 M(+2.8%) |
| June 2021 | - | -$214.63 M(+35.1%) |
| Mar 2021 | - | -$158.83 M(+4.9%) |
| Dec 2020 | -$151.41 M(+24.2%) | -$151.41 M(+5.9%) |
| Sept 2020 | - | -$143.02 M(+6.8%) |
| June 2020 | - | -$133.87 M(+9.8%) |
| Dec 2019 | -$121.91 M(+39.9%) | -$121.91 M |
| Dec 2018 | -$87.16 M | - |
FAQ
- What is Compass Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Compass Therapeutics?
- What is Compass Therapeutics annual retained earnings year-on-year change?
- What is Compass Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Compass Therapeutics?
- What is Compass Therapeutics quarterly retained earnings year-on-year change?
What is Compass Therapeutics annual retained earnings?
The current annual retained earnings of CMPX is -$315.31 M
What is the all time high annual retained earnings for Compass Therapeutics?
Compass Therapeutics all-time high annual retained earnings is -$87.16 M
What is Compass Therapeutics annual retained earnings year-on-year change?
Over the past year, CMPX annual retained earnings has changed by -$42.49 M (-15.58%)
What is Compass Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CMPX is -$349.65 M
What is the all time high quarterly retained earnings for Compass Therapeutics?
Compass Therapeutics all-time high quarterly retained earnings is -$121.91 M
What is Compass Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CMPX quarterly retained earnings has changed by -$47.76 M (-15.82%)